Disease-relevant molecules that cannot be pharmacologically targeted are sometimes referred to as undruggable, and in cancer, a number of proteins fall into this category. With innovation and new technologies, researchers make breakthroughs that turn evasive targets into druggable ones. Recent successes in establishing therapeutics against mutant oncoproteins, such as KRAS, transform the treatment landscape for patients and clinicians. A scientist who takes a unique approach to clinical trial design demonstrates how targeted small molecules are shifting drug discovery paradigms in oncology to better treat pancreatic cancer. In this episode, Deanna MacNeil from The Scientist’s Creative Services Team spoke with David Hong, the Dougie Johnson Endowed Professor and clinical medical director of the clinical trial research unit at MD Anderson Cancer Center, to learn more.   The Scientist Speaks is a podcast produced by The Scientist’s Creative Services Team. Our podcast is by scientists and for scientists. Once a month, we bring you the stories behind news-worthy molecular biology research. This month's episode is sponsored by Arima Genomics.

Jie Sun is a professor in Infectious Diseases and International Medicine at University of Virginia School of Medicine and associate director for Scientific Programs at the Carter Immunology Center. His philosophy of science prioritizes physiologically relevant infection models to tackle real-world clinical needs with research. In their latest work, Sun’s research team identified genetic and pharmacologic pathways that attenuate severe flu or COVID-19 infection and reduce blood glucose levels that spike after viral pneumonia. In this episode, Deanna MacNeil from The Scientist’s Creative Services Team spoke with Sun to learn more about his philosophy of science, which prioritizes physiologically relevant models of infection to tackle real-world clinical needs with research.   Science Philosophy in a Flash is a series of mini podcasts produced by The Scientist’s Creative Services Team. With a focus on the people behind the science, this podcast highlights researchers’ unique outlook on what motivates their pursuit of science and what it means to be a scientist.

David Liu is a professor in the Department of Chemistry and Chemical Biology at Harvard University. Liu’s lab has introduced breakthrough technologies to the field of genome editing, including base editing and prime editing, with the aim of treating genetic diseases. In their latest work, his research team took a “no stone unturned” approach to determine a one-time base editing strategy to treat the motor neuron disease, spinal muscular atrophy (SMA). In this episode, Deanna MacNeil from The Scientist’s Creative Services Team spoke with Liu to learn more about his philosophy of science, which involves an appreciation of fundamental principles in chemistry and evolution. Science Philosophy in a Flash is a series of mini podcasts produced by The Scientist’s Creative Services Team. With a focus on the people behind the science, this podcast highlights researchers’ unique outlook on what motivates their pursuit of science and what it means to be a scientist.

Claire Higgins is reader in the department of bioengineering at Imperial College London. Her philosophy of science involves a problem-solving approach to research, where she models tissue growth, development, and repair using human skin and hair follicles. In their latest work, her research team transplanted hair follicles into human skin scars in an attempt to make that tissue healthy again. In this episode, Iris Kulbatski from The Scientist’s Creative Services Team spoke with Higgins to learn more about how she takes an engineering-inspired, problem-solving approach to her research. To learn more about Higgins's research, check out this article.   Science Philosophy in a Flash is a series of mini podcasts produced by The Scientist’s Creative Services Team. With a focus on the people behind the science, this podcast highlights researchers’ unique outlook on what motivates their pursuit of science and what it means to be a scientist.

Scientists often refer to DNA as the blueprint of a cell. Whether the genetic material is single stranded or double stranded, linear or circular, organisms across the tree of life rely on their genomic blueprint for instructions on living, growing, and reproducing. Due to the amount of information carried by this blueprint, the size of the genome poses a biological dilemma; from humans to single-celled aquatic organisms, all eukaryotes must find a solution for organizing their DNA into a tiny nuclear space. In the quest for better tools to understand the 3D genomic architecture and the biological challenge of chromosome folding, a team of biochemistry and systems biology researchers investigated the unique genomic organization of unicellular marine plankton, dinoflagellates. In this episode, Deanna MacNeil from The Scientist’s Creative Services Team spoke with Job Dekker, a systems biology professor at the University of Massachusetts Chan Medical School and an investigator at the Howard Hughes Medical Institute, to learn more.   The Scientist Speaks is a podcast produced by The Scientist’s Creative Services Team. Our podcast is by scientists and for scientists. Once a month, we bring you the stories behind news-worthy molecular biology research. This month's episode is sponsored by Arima Genomics.